Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Deciphera Pharmaceuticals LLC)"
Count: 16
Selected: 0
NCT05957367A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies
NCT05734105A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
NCT05080621Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)
NCT05059262Study of Vimseltinib for Tenosynovial Giant Cell Tumor
NCT04892017A Phase 1/2 Study of DCC-3116 in Patients With MAPK Pathway Mutant Solid Tumors
NCT04530981A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GIST
NCT04148092Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST
NCT03717415A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors
NCT03673501A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
NCT03601897A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors
NCT03353753Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies
NCT03069469Study of DCC-3014 in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
NCT02571036A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
NCT02228811A Study of DCC-2701 in Participants With Advanced Solid Tumors
NCT00827138Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)
NCT02824575Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer